Difficulty: Medium
Average Score: 86%
Practice
Phenobarbitone is beneficial in the treatment of which of the following generalized seizures
Correct answer
A
Rationale
Phenobarbitone is a long-acting barbiturate that acts as a CNS depressant. It is particularly effective in treating tonic-clonic seizures, also known as grand mal seizures, which involve a combination of muscle rigidity and convulsions.
Option A, "Tonic-clonic seizures," is the correct answer because Phenobarbitone works by enhancing the activity of the inhibitory neurotransmitter GABA in the brain, which helps reduce the excessive neuronal activity associated with tonic-clonic seizures.
Option B, "Absence seizures," are characterized by brief lapses in consciousness and typically involve a different underlying mechanism compared to tonic-clonic seizures. Phenobarbitone is not the first-line treatment for absence seizures which are better managed with other anti-seizure medications.
Option C, "Atonic seizures," involve sudden loss of muscle tone and are also not typically treated with Phenobarbitone as these seizures have different triggers and mechanisms.
Option D, "All of the above," is incorrect because Phenobarbitone is not the preferred treatment for all types of generalized seizures.
In an educational context, it is crucial for healthcare professionals to understand the mechanisms of action and appropriate use of different anti-seizure medications to provide optimal care for patients with epilepsy and seizure disorders. Understanding the specificity of each drug for different seizure types helps in tailoring treatment plans to individual patient needs, ensuring better outcomes and minimizing side effects.
Option A, "Tonic-clonic seizures," is the correct answer because Phenobarbitone works by enhancing the activity of the inhibitory neurotransmitter GABA in the brain, which helps reduce the excessive neuronal activity associated with tonic-clonic seizures.
Option B, "Absence seizures," are characterized by brief lapses in consciousness and typically involve a different underlying mechanism compared to tonic-clonic seizures. Phenobarbitone is not the first-line treatment for absence seizures which are better managed with other anti-seizure medications.
Option C, "Atonic seizures," involve sudden loss of muscle tone and are also not typically treated with Phenobarbitone as these seizures have different triggers and mechanisms.
Option D, "All of the above," is incorrect because Phenobarbitone is not the preferred treatment for all types of generalized seizures.
In an educational context, it is crucial for healthcare professionals to understand the mechanisms of action and appropriate use of different anti-seizure medications to provide optimal care for patients with epilepsy and seizure disorders. Understanding the specificity of each drug for different seizure types helps in tailoring treatment plans to individual patient needs, ensuring better outcomes and minimizing side effects.